SCHEMBL24110588

SCHEMBL24110588

COc1cnc2c(ccn2CC(C)(C)N(C)C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HTR2C P28335 2/20 0.36
HTR2A P28223 1/20 0.36
DGAT1 O75907 1/20 0.32
GRM2 Q14416 1/20 0.32
PRMT5 O14744 2/20 0.32
GLO1 Q04760 1/20 0.31
USP2 O75604 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
TSHR P16473 1/20 0.31
CASP1 P29466 1/20 0.31
CYP2C19 P33261 1/20 0.31
CASP7 P55210 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30403505 0.78 HTR2C (0.57) MAPTKDM4EMEN1KMT2AHTR2C
SCHEMBL24109831 0.78 HTR2C (0.57) MAPTKDM4EMEN1KMT2AHTR2C
SCHEMBL29904400 0.78 HTR2C (0.54) MAPTKDM4EMEN1KMT2AHTR2C
SCHEMBL24109924 0.78 HTR2C (0.54) MAPTKDM4EMEN1KMT2AHTR2C
SCHEMBL25301751 0.76 HTR2C (0.43) MAPTKDM4EMEN1KMT2AHTR2C
SCHEMBL30404244 0.76 HTR2C (0.43) MAPTKDM4EMEN1KMT2AHTR2C
SCHEMBL24110220 0.76 HTR2C (0.43) MAPTKDM4EMEN1KMT2AHTR2C
SCHEMBL24110225 0.75 METAP2 (0.37) MAPTKDM4EMEN1KMT2AHTR2C
SCHEMBL24110586 0.75 MKNK2 (0.36) DGAT1PRMT5
SCHEMBL24110617 0.75 HTR2C (0.40) MAPTKDM4EMEN1KMT2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-13 US disclosed
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-13 US disclosed
WO-2021252692-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. (US) 2021-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF GAP43, SLC18A2, PNMT MAPT 254/4885KDM4E 2739/4885MEN1 3118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.